or Try an Advanced Search...

    Bruton's Tyrosine Kinase Stocks List

    Symbol Grade Name % Change
    NRIX B Nurix Therapeutics, Inc. 0.00
    BGNE D BeiGene, Ltd. 3.38
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Cancer Lymphoma Biotechnology Enzymes Gilead Sciences Immune Disorders Life Sciences Monoclonal Antibodies Monoclonal Antibody Oncogene Oncogenes Protein Kinase Ras Subfamily Rp1 Small Molecule Therapies Treatment Of Cancer Tyrosine Kinase

    Related ETFs - A few ETFs which own one or more of the above listed Bruton's Tyrosine Kinase stocks.

    Symbol Grade Name Weight
    KURE D KraneShares MSCI All China Health Care Index ETF 4.17
    IDNA C iShares Genomics Immunology and Healthcare ETF 3.57
    FBT D First Trust Amex Biotech Index Fund 3.3
    BBH D Market Vectors Biotech ETF 2.9
    ARKG F ARK Genomic Revolution Multi-Sector ETF 2.79
    View all Bruton's Tyrosine Kinase ETFs...
    Compare ETFs
    Compare BBH to ARKG Compare IDNA to FBT Compare KURE to ARKG

        Bruton's Tyrosine Kinase Stocks Recent News

        Date Stock Title
        Apr 26 BGNE BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
        Apr 25 BGNE 20 Countries with the Highest Rates of Stomach Cancer in the World
        Apr 24 BGNE Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting
        Apr 24 BGNE Evaluating BeiGene: Insights From 6 Financial Analysts
        Apr 23 BGNE EU regulators approve BeiGene's tislelizumab for lung cancer
        Apr 23 BGNE With 42% ownership of the shares, BeiGene, Ltd. (NASDAQ:BGNE) is heavily dominated by institutional owners
        Apr 23 BGNE BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Cancer Lymphoma Biotechnology Enzymes Gilead Sciences Immune Disorders Life Sciences Monoclonal Antibodies Monoclonal Antibody Oncogene Oncogenes Protein Kinase Ras Subfamily Rp1 Small Molecule Therapies Treatment Of Cancer Tyrosine Kinase
        Bruton's Tyrosine Kinase

        Bruton's Tyrosine Kinase (BTK) is an enzyme that is involved in the signaling pathways of B-cells, which are a type of white blood cell. BTK is essential for B-cell development and activation, and mutations in the BTK gene can lead to a variety of immunodeficiency disorders.

        Browse All Tags